Publication:
Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment

cris.virtual.author-orcid0000-0002-5062-1169
cris.virtual.author-orcid0000-0002-9404-7736
cris.virtualsource.author-orcid94c75969-f705-4199-98b7-38a3e11302d6
cris.virtualsource.author-orcid842b859b-8629-4695-95d7-9b78f1929bc8
cris.virtualsource.author-orcid6b9f7e28-8a66-49ee-abac-5a92d89b810b
cris.virtualsource.author-orcidf0bce958-a6b3-47a1-9d8a-ab6e62977be3
cris.virtualsource.author-orcide011d6de-b8e1-4d81-80b0-b19bf77501dd
cris.virtualsource.author-orcid50f55964-7ff8-4bc0-8549-9919a3cbee93
cris.virtualsource.author-orcid51cae653-8b4a-40cb-801b-42fa96a2f797
cris.virtualsource.author-orcidfe07c5e4-6205-4094-aebe-374a3866a26e
datacite.rightsrestricted
dc.contributor.authorWehrli, Marc
dc.contributor.authorSchorer, Myriam Fabiola
dc.contributor.authorHlushchuk, Ruslan
dc.contributor.authorDaudel, Fritz
dc.contributor.authorVilliger, Peter
dc.contributor.authorMiescher, Sylvia
dc.contributor.authorZuercher, Adrian W.
dc.contributor.authorDjonov, Valentin Georgiev
dc.contributor.authorSimon, Hans-Uwe
dc.contributor.authorvon Gunten, Stephan
dc.date.accessioned2024-10-23T17:21:53Z
dc.date.available2024-10-23T17:21:53Z
dc.date.issued2014-12
dc.description.abstractFcαRI (CD89), the human Fc receptor for IgA, is highly expressed on neutrophil granulocytes. In this study, we show that FcαRI induces different forms of neutrophil death, depending on the inflammatory microenvironment. The susceptibility of inflammatory neutrophils from sepsis or rheumatoid arthritis toward death induced by specific mAb, or soluble IgA at high concentrations, was enhanced. Although unstimulated cells experienced apoptosis following anti-FcαRI mAb stimulation, preactivation with cytokines or TLR agonists in vitro enhanced FcαRI-mediated death by additional recruitment of caspase-independent pathways, but this required PI3K class IA and MAPK signaling. Transmission electron microscopy of FcαRI-stimulated cells revealed cytoplasmic changes with vacuolization and mitochondrial swelling, nuclear condensation, and sustained plasma membrane. Coculture experiments with macrophages revealed anti-inflammatory effects of the partially caspase-independent death of primed cells following FcαRI engagement. Our data suggest that FcαRI has the ability to regulate neutrophil viability and to induce different forms of neutrophils depending on the inflammatory microenvironment and specific characteristics of the ligand-receptor interactions. Furthermore, these findings have potential implications for FcαRI-targeted strategies to treat neutrophil-associated inflammatory diseases.
dc.description.numberOfPages11
dc.description.sponsorshipInstitut für Pharmakologie
dc.description.sponsorshipInstitut für Anatomie
dc.description.sponsorshipUniversitätsklinik für Intensivmedizin
dc.description.sponsorshipUniversitätsklinik für Rheumatologie, Klinische Immunologie und Allergologie
dc.identifier.doi10.7892/boris.61962
dc.identifier.pmid25339672
dc.identifier.publisherDOI10.4049/jimmunol.1400028
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/128493
dc.language.isoen
dc.publisherAmerican Association of Immunologists
dc.relation.ispartofJournal of immunology
dc.relation.issn0022-1767
dc.relation.organizationDCD5A442BCD7E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BAD8E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BADDE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BD11E17DE0405C82790C4DE2
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleHuman IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage5659
oaire.citation.issue11
oaire.citation.startPage5649
oaire.citation.volume193
oairecerif.author.affiliationInstitut für Pharmakologie
oairecerif.author.affiliationInstitut für Pharmakologie
oairecerif.author.affiliationInstitut für Anatomie
oairecerif.author.affiliationUniversitätsklinik für Intensivmedizin
oairecerif.author.affiliationUniversitätsklinik für Rheumatologie, Klinische Immunologie und Allergologie
oairecerif.author.affiliationInstitut für Anatomie
oairecerif.author.affiliationInstitut für Pharmakologie
oairecerif.author.affiliationInstitut für Pharmakologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2017-09-10 05:58:25
unibe.description.ispublishedpub
unibe.eprints.legacyId61962
unibe.journal.abbrevTitleJ IMMUNOL
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
J Immunol-2014-Wehrli-5649-59.pdf
Size:
1.48 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections